Losartan inhibits sars-cov-2 replication in vitro

Reza Nejat, Ahmad Shahir Sadr, Brendan T. Freitas, Jackelyn Murray, Scott D. Pegan, Ralph A. Tripp, David J. Najafi

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)
14 Downloads (Pure)

Abstract

Purpose: SARS-CoV-2 infection is associated with substantial mortality and high morbidity. This study tested the effect of angiotensin II type I receptor blocker, losartan, on SARS-CoV-2 replication and inhibition of the papain-like protease of the virus. Methods: The dose-dependent inhibitory effect of losartan, in concentrations from 1μM to 100μM as determined by quantitative cell analysis combining fluorescence microscopy, image processing, and cellular measurements (Cellomics analysis) on SARS-CoV-2 replication was investigated in Vero E6 cells. The impact of losartan on deubiquitination and deISGylation of SARS-CoV-2 papain-like protease (PLpro) were also evaluated. Results: Losartan reduced PLpro cleavage of tetraUbiquitin to diUbiquitin. It was less effective in inhibiting PLpro’s cleavage of ISG15-AMC than Ubiquitin-AMC. To determine if losartan inhibited SARS-CoV-2 replication, losartan treatment of SARS-CoV-2 infected Vero E6 was examined. Losartan treatment one hour prior to SARS-CoV-2 infection reduced levels of SARS-CoV-2 nuclear protein, an indicator of virus replication, by 80% and treatment one-hour post-infection decreased viral replication by 70%. Conclusion: Losartan was not an effective inhibitor of deubiquitinase or deISGylase activity of the PLpro but affected the SARS-CoV-2 replication of Vero E6 cells in vitro. As losartan has a favorable safety profile and is currently available it has features necessary for efficacious drug repurposing and treatment of COVID-19.

Original languageEnglish
Pages (from-to)390-399
Number of pages10
JournalJournal of Pharmacy and Pharmaceutical Sciences
Volume24
DOIs
Publication statusPublished - 31 May 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Losartan inhibits sars-cov-2 replication in vitro'. Together they form a unique fingerprint.

Cite this